Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 17 Sept, 01:30 am
GSK , a major biopharmaceutical company, shows potential for nearly 20% upside according to analysts, despite recent stock declines. The company is significantly strengthening its oncology drug pipeline through strategic acquisitions and promising clinical trial results for treat
Analyst Confidence: Multiple firms like Oppenheimer and Argus have upgraded or reiterated positive ratings for Etsy, signaling a strong belief in its future stock performance. Strategic Growth: Etsy's new partnership with Remitly Global, Inc. aims to enhance international payment
Immersion Corporation (NASDAQ: IMMR) Returns to Profit in Q1 FY2027 as Revenue Edges Higher Immersion Corporation (NASDAQ: IMMR) reported consolidated revenue of $294.40 million , up approximately 0.8% year over year. GAAP net income attributable to Immersion stockholders reached
Financial Underperformance: Ocean Power Technologies, Inc. (AMEX:OPTT) reported a significant Q1 EPS miss and lower-than-expected revenue , continuing a trend of financial underperformance in the alternative energy sector . Operational Strengths: Despite financial challenges, OPT
Radiant Logistics significantly surpassed analyst expectations with an EPS of $0.15 and revenue of $261.44 million . The company demonstrated enhanced operational efficiency, with Adjusted EBITDA increasing by 31.6% and its Adjusted EBITDA margin expanding by 240 basis points . R
Jefferies analyst raises price target for Scholar Rock to $65 from $57 . Scholar Rock received U.S. Food and Drug Administration (FDA) approval for ISEMBYLD, a new treatment for spinal muscular atrophy (SMA). ISEMBYLD is the first muscle-targeted therapy for SMA, with a list pric
Dave & Buster's Entertainment, Inc. (NASDAQ: PLAY) reported a significant earnings per share (EPS) miss and an adjusted net loss for Q2 2026, reversing previous year's profits. The company experienced a revenue decline, falling short of analyst estimates and showing a year-over-y
Stock Market Downturn: Key Factors Behind Today's Top Losers and Investor Uncertainty Minimal-revenue or pre-revenue strategies can increase investor uncertainty when risk appetite weakens. Leveraged ETFs carry high risks because they magnify daily gains and losses from their und
Top Stock Gainers Today: Corporate News Fuels Significant Market Moves Future FinTech (NASDAQ: FTFT) surged following its recent 1-for-4 reverse stock split and heavy trading activity. Basel Medical Group Ltd. (NASDAQ: BMGL) climbed sharply, while Vince Holding Corp. (NASDAQ: VNC
Hub Group (NASDAQ: HUBG) Faces Headwinds: Analyst Price Target and Operational Challenges An analyst's price target for Hub Group (NASDAQ: HUBG) is set just below its current trading price, suggesting limited upside potential for the logistics stock. Hub Group's stock performance
Coda Octopus Group (NASDAQ:CODA) surpassed third-quarter analyst expectations, reporting an earnings per share (EPS) of $0.12 and revenue of $7.7 million . The company's growth was primarily fueled by its defense engineering and acoustic businesses , successfully offsetting a dec
Lennar Corporation (NYSE: LEN) is set to release its Q3 earnings amidst a critical week for the housing market and broader economic indicators, including potential Fed interest rate adjustments. Analysts project a year-over-year decline in Q3 earnings per share (EPS) and revenue
The Baldwin Group (NASDAQ: BWIN) Goes Private Amid Analyst Downgrade and Shareholder Scrutiny The Baldwin Group (NASDAQ: BWIN) is set to go private through a transaction led by Sequence Holdings and DFO Management, the Dell Family Office. The all-cash transaction implies an enter
BTIG increased its price target for Cullinan Therapeutics to $40 , suggesting a potential upside of approximately 93% from its current stock price. This positive outlook stems from successful Phase 3 REZILIENT3 trial results for zipalertinib, a key therapy for non-small cell lung
Tesla (NASDAQ: TSLA) Faces Investment Scrutiny Amid Growth Initiatives and Market Challenges Tesla (NASDAQ: TSLA) is facing investor scrutiny as large investments in AI , autonomy , robotics , and manufacturing capacity pressure margins and free cash flow . Analyst sentiment rema
An analyst at Telsey Advisory set a new price target of $75.00 for Kroger, suggesting a potential 23.50% upside from its trading price of $60.73 . Kroger reported mixed Q2 results, with adjusted EPS of $1.09 surpassing estimates, but total revenues of $34.62 billion falling sligh
Enbridge Inc. (NYSE: ENB) Navigates Market Volatility Amid Strategic Acquisitions and Leadership Change Enbridge Inc. (NYSE: ENB) , a leading North American energy infrastructure company , is facing market volatility while pursuing major expansion moves. The company announced the
RF Industries reported a slight earnings miss but demonstrated substantial year-over-year EPS growth. The company achieved record quarterly revenue, exceeding analyst expectations and showing strong growth in the radio frequency semiconductor industry . Improved profitability was
Headlines provided by Investing.com